GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 ()

GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 () | aktiencheck.de

Related Keywords

Italy ,Australia ,Japan ,Switzerland ,United States ,Allschwil ,Switzerland General ,Milan ,Lombardia ,American ,Swiss ,Markus Schlaich ,Arthurc Corcoran ,Andrewc Weiss ,International Society Of Hypertension ,European Society ,Idorsia Pharmaceuticals Ltd ,Head Of Investor Relations Corporate Communications ,Swiss Exchange ,Idorsia Ltd ,American Heart Association ,European Society Of Hypertension ,Hypertension Council ,European Society Of Cardiology ,European Meeting ,Uncontrolled Hypertension ,Breaking Science ,Management Board ,High Blood ,Editorial Board ,Vice President ,Investor Relations ,Pharmaceuticals Ltd ,Des Tages ,Aktien ,örse ,Ktiencheck ,Ktienkultur ,Ktienanalysen ,Ktienempfehlungen ,Nalysen ,örsennachrichten ,Nalysten ,Research ,Eldanlage ,Investment ,örsenkurse ,Nurse ,Charts ,Intraday ,Arktberichte ,Ewsletter ,Ecdax ,Dax ,Tax ,Ebenwerte ,Dhoc ,örseninformationen ,örsenbriefe ,örsenbrief ,Ertpapiere ,Mpfehlungen ,Warrants ,Bonds ,Ptionsscheine ,S Rechner ,S Vergleich ,Nut ,Wall ,Ptionsscheinecheck ,Euemissionen ,Ertifikate ,Ohstoffe ,Nleihen ,Evisen ,